🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 21 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 15/10/2004 | 33,72 | 33,80 | 32,00 | 32,15 | -4,56% | 5,33% | 375.236 |
| 14/10/2004 | 33,65 | 33,87 | 32,94 | 33,69 | +0,67% | 2,78% | 137.591 |
| 13/10/2004 | 35,18 | 35,48 | 33,46 | 33,46 | -4,38% | 5,74% | 123.351 |
| 12/10/2004 | 35,75 | 35,75 | 34,25 | 35,00 | -1,58% | 4,19% | 218.489 |
| 11/10/2004 | 34,62 | 35,71 | 34,59 | 35,56 | +2,48% | 3,24% | 145.312 |
| 08/10/2004 | 36,31 | 36,31 | 34,70 | 34,70 | -3,64% | 4,43% | 132.248 |
| 07/10/2004 | 36,72 | 37,62 | 35,93 | 36,01 | -3,32% | 4,59% | 152.098 |
| 06/10/2004 | 37,84 | 38,18 | 36,34 | 37,24 | -1,97% | 4,85% | 321.695 |
| 05/10/2004 | 39,23 | 39,26 | 37,24 | 37,99 | -2,59% | 5,15% | 263.747 |
| 04/10/2004 | 38,25 | 39,45 | 38,07 | 39,00 | +2,56% | 3,62% | 331.207 |
| 01/10/2004 | 37,54 | 38,25 | 37,17 | 38,03 | +1,40% | 2,89% | 372.991 |
| 30/09/2004 | 39,64 | 40,35 | 37,39 | 37,50 | +0,20% | 7,46% | 689.317 |
| 29/09/2004 | 37,95 | 38,07 | 36,98 | 37,43 | -1,48% | 2,86% | 309.646 |
| 28/09/2004 | 38,44 | 38,52 | 37,47 | 37,99 | +0,00% | 2,73% | 167.407 |
| 27/09/2004 | 38,89 | 38,96 | 37,95 | 37,99 | -3,79% | 2,60% | 181.673 |
| 24/09/2004 | 41,21 | 41,92 | 39,34 | 39,49 | -4,18% | 6,27% | 149.293 |
| 23/09/2004 | 39,90 | 41,70 | 39,86 | 41,21 | +3,19% | 4,60% | 138.018 |
| 22/09/2004 | 41,92 | 42,03 | 39,83 | 39,94 | -4,99% | 5,27% | 224.714 |
| 21/09/2004 | 42,00 | 42,71 | 41,43 | 42,03 | +0,00% | 3,03% | 185.681 |
| 20/09/2004 | 41,92 | 43,01 | 40,84 | 42,03 | +0,27% | 5,18% | 329.310 |
| 17/09/2004 | 42,60 | 44,09 | 40,84 | 41,92 | -0,88% | 7,65% | 334.546 |
| 16/09/2004 | 39,68 | 43,98 | 39,64 | 42,30 | +5,02% | 10,94% | 606.094 |
| 15/09/2004 | 40,12 | 40,87 | 37,80 | 40,27 | +0,00% | 7,65% | 115.870 |
| 14/09/2004 | 40,99 | 41,02 | 39,45 | 40,27 | -1,74% | 3,84% | 141.678 |
| 13/09/2004 | 38,93 | 41,06 | 38,81 | 40,99 | +5,59% | 5,77% | 278.281 |
| 10/09/2004 | 38,70 | 39,60 | 38,18 | 38,81 | +1,87% | 3,67% | 413.093 |
| 09/09/2004 | 37,36 | 38,37 | 37,13 | 38,10 | +2,11% | 3,31% | 160.140 |
| 08/09/2004 | 38,18 | 38,22 | 37,24 | 37,32 | -2,06% | 2,55% | 132.461 |
| 07/09/2004 | 37,69 | 39,08 | 37,69 | 38,10 | +1,09% | 3,67% | 175.128 |
| 03/09/2004 | 39,23 | 39,41 | 37,54 | 37,69 | -3,45% | 4,77% | 176.303 |